Lipid Nanoparticle Products

Introduction of Lipid Nanoparticles (LNPs)

LNP-1 (Creative Biolabs Original)

Lipid Nanoparticles (LNPs) are lipid vesicles with a uniform lipid core, prepared from ionizable/cationic lipids, helper/structural lipid, cholesterol, and PEGylated lipids, with a diameter of around 100 nm. Their unique structure and size give them special physical and chemical properties, making them effective for encapsulating and protecting nucleic acid drugs like mRNA, siRNA, and DNA. LNPs can adhere to negatively charged cell membranes and are taken up by cells via endocytosis, forming endosomes. These mature endosomes fuse with lysosomes, where the acidic environment triggers the protonation of ionizable lipids, giving them a positive charge. This allows LNPs to escape the endosomes and release their nucleic acid cargo into the cytoplasm.

Advantages and Applications of Lipid Nanoparticles

  • High Payload Capacity and Delivery Efficiency: LNPs can effectively encapsulate and protect long nucleic acid drugs, preventing their degradation and premature release during delivery.
  • Surface Modification: By conjugating LNPs with antibodies, peptides, and other ligands, targeted delivery to specific tissues, organs, and cells can be achieved.
  • Nucleic Acid Delivery: LNPs can carry various nucleic acids, including mRNA, siRNA, circular RNA, antisense oligonucleotides, and DNA.
  • Gene Editing: LNPs can be loaded with Cas9 mRNA and sgRNA to prepare CRISPR-LNPs for gene editing applications.
  • CAR-T Therapy: LNPs can facilitate in vivo CAR T cell production by delivering CAR mRNA to lymphocytes, offering efficient delivery, low immunogenicity, and reduced risk of insertional mutagenesis.
  • SORT Technology: Based on traditional four-component lipids, introducing a fifth lipid component enables targeted delivery to specific tissues, organs, and cells.
SORT Molecule Charge Lipid Target
Cationic Lipid Positive 50% DOTAP Lung
Anionic Lipid Negative 10-40% 18PA Spleen

Creative Biolabs' Lipid Nanoparticle Products

Ionizable/cationic lipids are key to LNP development. We offer off-the-shelf LNPs with diverse ionizable lipids, customizable with capped/modified nucleic acids.

  • LNPs for delivering various nucleic acids (reporter genes, gene-editing, vaccines/antigens, etc.).
  • Empty LNPs as controls to find the optimal LNP formula.
  • mRNA with/without caps and modifications to boost expression and reduce immunogenicity.
  • Suitable for both cellular and animal experiments.

For specific needs, explore our LNP development services or email us at info@creative-biolabs.com for details.

Please refer to our detailed list of LNP products:

Quality Control

Creative Biolabs guarantees the supply of LNPs with uniform particle size and exceptional stability, ensuring dependable and effective genetic material delivery for a wide range of research applications.

Item Method Specification
Particle size Dynamic light scattering Uniform size distribution (typically around 100nm)
Poly Dispersity Index (PDI) Dynamic light scattering < 0.3
Zeta Potential Dynamic light scattering Varies with different lipid compositions
Encapsulation Efficiency RiboGreen >85%
Concentration RiboGreen Customizable concentration
*For more testing items, please contact us.
  • Case Study: SM102 LNP-Fluc mRNA (m1Ψ) ( CAT#: LDLY-0325-LD501)
  • Size (Z-average): The average hydrodynamic diameter of nanoparticles, reflecting the overall particle size in solution.
  • PDI: A measure of nanoparticle size uniformity and distribution width.

Case-LNP (Creative Biolabs Original)

FAQs

What is the significance of Zeta Potential in LNPs?
I need assistance designing my LNP formulation. Do you offer consulting services?
What is the shelf life of Creative Biolabs' LNP products?
What is the delivery efficiency of Creative Biolabs' LNPs for different types of nucleic acids?
What is the estimated delivery period for custom LNP orders?
Can I provide a reference for the LNP formulation I need?
Can I get LNPs with specific fluorescence labels for tracking purposes?
I need to scale up my LNP production for a larger study. Can you support this?

Resources

 

For Research Use Only. Not For Clinical Use

Products

Liposomes Lipid Nanoparticles
Lipids Kits
    Cat Product name Ionizable/Cationic Lipid Cargo Modification Application Data sheet MSDS Inquiry
    LDLY-0325-LD920 SM102 LNP-CD19 CAR mRNA SM102 CD19 CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD921 DLin-MC3-DMA LNP-BCMA CAR mRNA DLin-MC3-DMA BCMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD922 LP-01 LNP-BCMA CAR mRNA LP-01 BCMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD923 ALC-0315 LNP-BCMA CAR mRNA ALC-0315 BCMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD924 SM102 LNP-BCMA CAR mRNA SM102 BCMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD925 DLin-MC3-DMA LNP-HER2 CAR mRNA DLin-MC3-DMA HER2 CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD926 LP-01 LNP-HER2 CAR mRNA LP-01 HER2 CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD927 ALC-0315 LNP-HER2 CAR mRNA ALC-0315 HER2 CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD928 SM102 LNP-HER2 CAR mRNA SM102 HER2 CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD929 DLin-MC3-DMA LNP-PSMA CAR mRNA DLin-MC3-DMA PSMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD930 LP-01 LNP-PSMA CAR mRNA LP-01 PSMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD931 ALC-0315 LNP-PSMA CAR mRNA ALC-0315 PSMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD932 SM102 LNP-PSMA CAR mRNA SM102 PSMA CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD933 DLin-MC3-DMA LNP-CD37 CAR mRNA DLin-MC3-DMA CD37 CAR mRNA mRNA delivery; CAR-T Inquiry
    LDLY-0325-LD934 LP-01 LNP-CD37 CAR mRNA LP-01 CD37 CAR mRNA mRNA delivery; CAR-T Inquiry
    Can't find the products you're looking for?
    Optimize our parameters for better results.
    Filter By Tag

    Online Inquiry

    Close
    Thanksgiving
    Thanksgiving